Pancreatic Cancer Research

ResearcherPhusis Therapeutics, Inc.No recent work listed

Garth Powis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3976-8415; OpenAlex author ID A5011101496; NIH RePORTER profile ID 1869258. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
2
Labs led
3
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 grant · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 grant

Papers 2

  1. Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer. Last author DOI 10.1158/0008-5472.can-11-1433↗
  2. Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cells. Co-author DOI 10.1158/1541-7786.mcr-11-0359↗

Grants 2

  1. Inhibiting Multi-Functional ALDOA for Cancer Therapy R01CA216424↗
  2. Exploiting tumor stroma interactions for cancer therapy R01CA163541↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert T. Dorr · 1 shared paper, 2012 · strength 0.04
  2. Betty K. Samulitis · 1 shared paper, 2012 · strength 0.04
  3. Terry H. Landowski · 1 shared paper, 2012 · strength 0.04
  4. Elena V. Sheveleva · 1 shared paper, 2012 · strength 0.04
  5. Taly R. Spivak-Kroizman · 1 shared paper, 2013 · strength 0.03
  6. Sunil R. Hingorani · 1 shared paper, 2013 · strength 0.03
  7. Daniel D. Von Hoff · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.